Kiersten Pflueger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kiersten Pflueger has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Biren Saraiya
2 shared publications- Paul R. Duberstein
Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA
2 shared publications Anastasia Bakoulis
Division of Breast Surgery, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY, USA
1 shared publicationAndrew S. Epstein
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
1 shared publicationAnne Moyer
Department of Psychology, Stony Brook University, Stony Brook, NY, USA
1 shared publication- Barbara Nemesure
Stony Brook Medicine
1 shared publication
Latest Publications
- 14 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 290-297
Patient experiences with same-day discharge after prepectoral implant-based breast reconstruction
- 14 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 290-297
Patient experiences with same-day discharge after prepectoral implant-based breast reconstruction
- Open Access
Factors Associated with HPV Vaccine Uptake in College Students Following the COVID-19 Pandemic
Background: Most cancers caused by human papillomavirus (HPV) are preventable through vaccination, yet uptake among U.S. college students remains below national targets. This study examined HPV vaccination rates and factors associated with vaccine uptake among students aged 18–26 years at a large, diverse public university in New York State following the COVID-19 pandemic. Methods: In March 2022, an online survey was distributed to 19,351 students aged 18–26 years; responses were received from 708 students (~4%) and included in the analysis. Descriptive statistics and multivariable logistic regression was used to identify predictors of HPV vaccination. Results: Overall, 59% of students reported receiving at least one HPV vaccine dose, while 17.7% were unsure of their vaccination status. Among students whose healthcare provider recommended the HPV vaccine, 76.4% were vaccinated compared to 16.7% without one (p < 0.001). Healthcare provider recommendation was the strongest predictor of vaccination (OR 17.9; 95% CI: 8.45–37.91). Additional factors significantly associated with uptake included agreement that the HPV vaccine is safe (OR 2.56; 95% CI: 1.54–4.27), importance of a sexual partner being vaccinated (OR 2.65; 95% CI: 1.90–3.69), and valuing family opinion (OR 1.67; 95% CI: 1.23–2.26). Students most preferred receiving HPV information from healthcare providers (73.4%), followed by Internet searches (51.8%) and social media (35.1%). Conclusions: HPV vaccination uptake among college students remains below national targets. Strengthening provider recommendations, addressing safety concerns, and implementing multimodal education strategies during preventive visits for young adults are essential to improve coverage and reduce HPV-related cancer risk.
Open AccessFactors Associated with HPV Vaccine Uptake in College Students Following the COVID-19 Pandemic
Background: Most cancers caused by human papillomavirus (HPV) are preventable through vaccination, yet uptake among U.S. college students remains below national targets. This study examined HPV vaccination rates and factors associated with vaccine uptake among students aged 18–26 years at a large, diverse public university in New York State following the COVID-19 pandemic. Methods: In March 2022, an online survey was distributed to 19,351 students aged 18–26 years; responses were received from 708 students (~4%) and included in the analysis. Descriptive statistics and multivariable logistic regression was used to identify predictors of HPV vaccination. Results: Overall, 59% of students reported receiving at least one HPV vaccine dose, while 17.7% were unsure of their vaccination status. Among students whose healthcare provider recommended the HPV vaccine, 76.4% were vaccinated compared to 16.7% without one (p < 0.001). Healthcare provider recommendation was the strongest predictor of vaccination (OR 17.9; 95% CI: 8.45–37.91). Additional factors significantly associated with uptake included agreement that the HPV vaccine is safe (OR 2.56; 95% CI: 1.54–4.27), importance of a sexual partner being vaccinated (OR 2.65; 95% CI: 1.90–3.69), and valuing family opinion (OR 1.67; 95% CI: 1.23–2.26). Students most preferred receiving HPV information from healthcare providers (73.4%), followed by Internet searches (51.8%) and social media (35.1%). Conclusions: HPV vaccination uptake among college students remains below national targets. Strengthening provider recommendations, addressing safety concerns, and implementing multimodal education strategies during preventive visits for young adults are essential to improve coverage and reduce HPV-related cancer risk.
- Open Access
- 19 September 2024
- Published by Center for Open Science in PsyArXiv
How Psychology Can Ease End-of-Life Challenges: Modifying Social Norms Around Death and Dying in the US
In the context of life-limiting illness, spending more on healthcare and prescribing more invasive disease-directed treatments often leads to worse quality-of-life outcomes for patients and caregivers while increasing medical debt. Current approaches to mitigating these harms are inadequate, necessitating new conceptual frameworks to guide research, interventions, and policy. The Transtheoretical Model of Irrational Biomedical Exuberance (TRIBE) leverages psychological research and theory to explain how moral emotions (e.g., compassion, pride, shame) experienced by clinicians, patients, and their families lead to the prescription of disease-directed interventions (e.g., chemotherapy, dialysis) that often cause more harm than benefit. In this extension of the TRIBE model to the broader US health policy context, we posit that moral emotional processes also influence healthcare policy and commercialized healthcare delivery. Specifically, we posit that death decorum norms and corresponding moral emotions (e.g., compassion) motivate harmful end-of-life interventions by eroding death literacy and stoking death anxiety. Similarly, commercialization norms and corresponding moral emotions (e.g., pride) motivate the overuse of biomedical interventions and lead clinicians, patients, policymakers, and the public to place undue faith in biotechnology. Socioemotional processes obscure financial motives that incentivize disease-directed treatments while disincentivizing psychological interventions and the development of community-based interventions and systems of care. Given psychologists’ expertise in behavior, emotions, and systems-level culture change, they are uniquely positioned to mitigate the harms of disease-directed treatments at the end-of-life. Opportunities abound for psychologists to contribute to transdisciplinary research, interventions, policy, and culture change initiatives aimed at easing the challenges associated with end-of-life transitions and promoting higher quality care.
- 19 September 2024
- Published by Center for Open Science in PsyArXiv
Open AccessHow Psychology Can Ease End-of-Life Challenges: Modifying Social Norms Around Death and Dying in the US
In the context of life-limiting illness, spending more on healthcare and prescribing more invasive disease-directed treatments often leads to worse quality-of-life outcomes for patients and caregivers while increasing medical debt. Current approaches to mitigating these harms are inadequate, necessitating new conceptual frameworks to guide research, interventions, and policy. The Transtheoretical Model of Irrational Biomedical Exuberance (TRIBE) leverages psychological research and theory to explain how moral emotions (e.g., compassion, pride, shame) experienced by clinicians, patients, and their families lead to the prescription of disease-directed interventions (e.g., chemotherapy, dialysis) that often cause more harm than benefit. In this extension of the TRIBE model to the broader US health policy context, we posit that moral emotional processes also influence healthcare policy and commercialized healthcare delivery. Specifically, we posit that death decorum norms and corresponding moral emotions (e.g., compassion) motivate harmful end-of-life interventions by eroding death literacy and stoking death anxiety. Similarly, commercialization norms and corresponding moral emotions (e.g., pride) motivate the overuse of biomedical interventions and lead clinicians, patients, policymakers, and the public to place undue faith in biotechnology. Socioemotional processes obscure financial motives that incentivize disease-directed treatments while disincentivizing psychological interventions and the development of community-based interventions and systems of care. Given psychologists’ expertise in behavior, emotions, and systems-level culture change, they are uniquely positioned to mitigate the harms of disease-directed treatments at the end-of-life. Opportunities abound for psychologists to contribute to transdisciplinary research, interventions, policy, and culture change initiatives aimed at easing the challenges associated with end-of-life transitions and promoting higher quality care.
- 1 October 2023
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 26 (10) , 1386-1390
Feasibility and Acceptability of an Online Oncologist Training to Optimize Oncologist–Patient Communication and Value-Concordant Care in Advanced Cancer
Introduction: This pilot study tested the feasibility and acceptability of a low-resource-intensive scalable online communication training designed to improve oncologists' skills in prognostic and value-concordant care discussions with advanced cancer patients. Methods: The training consisted of on-demand videos on how to convey prognostic information, manage patient emotions, and elicit patient values and incorporate these values into treatment decision making. Post-intervention, oncologists reported on their perceptions of the training. Results: Fifteen oncologists were enrolled, of whom, 13 completed the training, and 14 completed post-intervention interviews. Most oncologists reported the intervention was acceptable: 92.9% indicated the intervention was “moderately” to “very helpful”; 78.6% rated it as “somewhat” to “very much” impactful on their communication with patients. Conclusions: The present self-paced online communication training was acceptable to oncologists, supporting additional research, including evaluating intervention efficacy for improving oncologists' communication skills and value-concordant care in advanced cancer.
- 1 October 2023
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 26 (10) , 1386-1390
Feasibility and Acceptability of an Online Oncologist Training to Optimize Oncologist–Patient Communication and Value-Concordant Care in Advanced Cancer
Introduction: This pilot study tested the feasibility and acceptability of a low-resource-intensive scalable online communication training designed to improve oncologists' skills in prognostic and value-concordant care discussions with advanced cancer patients. Methods: The training consisted of on-demand videos on how to convey prognostic information, manage patient emotions, and elicit patient values and incorporate these values into treatment decision making. Post-intervention, oncologists reported on their perceptions of the training. Results: Fifteen oncologists were enrolled, of whom, 13 completed the training, and 14 completed post-intervention interviews. Most oncologists reported the intervention was acceptable: 92.9% indicated the intervention was “moderately” to “very helpful”; 78.6% rated it as “somewhat” to “very much” impactful on their communication with patients. Conclusions: The present self-paced online communication training was acceptable to oncologists, supporting additional research, including evaluating intervention efficacy for improving oncologists' communication skills and value-concordant care in advanced cancer.